Preliminary interim results of the first-in-human, dose-finding PROCLAIM-CX-072 trial of the PD-L1 Probody therapeutic (Pb-Tx) CX-072 in combination with ipilimumab (ipi) in patients (pts) with advanced solid tumors Meeting Abstract
| Authors: | Sanborn, R. E.; Menke, C. W.; Autio, K. A.; Arkenau, H. T.; Corbacho, J. G.; LoRusso, P.; Plummer, E. R.; Uboha, N. V.; Freeman, M. L.; Wydmanski, J.; Huels, V.; Zheng, B.; Will, M.; Humphrey, R. W.; Thistlethwaite, F.; de Vries, E. G. E.; El-Khoueiry, A. B. |
| Abstract Title: | Preliminary interim results of the first-in-human, dose-finding PROCLAIM-CX-072 trial of the PD-L1 Probody therapeutic (Pb-Tx) CX-072 in combination with ipilimumab (ipi) in patients (pts) with advanced solid tumors |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 154s |
| Language: | English |
| ACCESSION: | WOS:000442916001444 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.3072 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 3072 -- Source: Wos |
